1.
Rodriguez Arroyo BP, Mondragón-Cardona A, Pacheco-Orozco RA, Tamayo A, Moreno JC, Baena-Valencia JC. Partial response to treatment with ALK inhibitor in a patient with SQSTM1-ALK fusion positive lung adenocarcinoma. EJCRIM [Internet]. 2024 Nov. 15 [cited 2026 Nov. 3];11(12). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4887